Table 1.
Prevalence and features of human blood stage malaria parasites.
Parasite species | Prevalence | Erythrocyte stage life cycle duration | Merozoite numbers in matured IRBCs | Cytoadherence capacity and organs where adherence occurs | Frequency of causing severe illnesses and fatality | References |
---|---|---|---|---|---|---|
P. falciparum | Worldwide (high prevalence in Africa) | 48 h | 8–24 | Strong; in most organs, including skin, intestine and placenta | Often causes severe illnesses, highly fatal | (53) |
P. vivax | Asia, Latin America, some parts of Africa | 48 h | 12–18 | Weak; mostly in lungs | Mostly uncomplicated malaria, occasionally fatal | (53) |
P. ovale | Africa, Western pacific islands | 48 h | 8–16 | Absent | Mostly uncomplicated malaria, fatality is rare | (53, 54) |
P. malariae | Worldwide | 72 h | 6–12 | Absent | Mostly uncomplicated malaria, fatality is rare | (53, 54) |
P. knowlesi | Southeast Asia | 24 h | Up to 16 | Weak; in lungs, and likely brain and other organs | Uncomplicated to severe illnesses (60–70% of infected cases develop ARDSa) | (8, 9, 55) |
ARDS, acute respiratory distress syndrome.